Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
Ledgerwood LG, Kumar D, Eterovic AK, Wick J, Chen K, Zhao H, Tazi L, Manna P, Kerley S, Joshi R, Wang L, Chiosea SI, Garnett JD, Tsue TT, Chien J, Mills GB, Grandis JR, Thomas SM. Ledgerwood LG, et al. Among authors: wick j. Oncotarget. 2016 May 10;7(19):27185-98. doi: 10.18632/oncotarget.8448. Oncotarget. 2016. PMID: 27034009 Free PMC article.
T-cell trafficking plays an essential role in tumor immunity.
Aires DJ, Yoshida M, Richardson SK, Bai M, Liu L, Moreno R, Lazar AJF, Wick JA, Rich BE, Murphy G, Blumberg RS, Fuhlbrigge RC, Kupper TS. Aires DJ, et al. Among authors: wick ja. Lab Invest. 2019 Jan;99(1):85-92. doi: 10.1038/s41374-018-0124-6. Epub 2018 Oct 23. Lab Invest. 2019. PMID: 30353131 Free PMC article.
A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancer.
Huang CH, Wick JA, Sittampalam GS, Nirmalanandhan VS, Ganti AK, Neupane PC, Williamson SK, Godwin AK, Schmitt S, Smart NJ, Spencer S, Van Veldhuizen PJ. Huang CH, et al. Among authors: wick ja. Front Oncol. 2014 Oct 14;4:271. doi: 10.3389/fonc.2014.00271. eCollection 2014. Front Oncol. 2014. PMID: 25353007 Free PMC article.
Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer.
Huang CH, Williamson SK, Neupane P, Taylor SA, Allen A, Smart NJ, Uypeckcuat AM, Spencer S, Wick J, Smith H, Van Veldhuizen PJ, Kelly K. Huang CH, et al. Among authors: wick j. Front Oncol. 2016 Jan 13;5:301. doi: 10.3389/fonc.2015.00301. eCollection 2015. Front Oncol. 2016. PMID: 26793618 Free PMC article.
A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.
Williamson SK, Johnson GA, Maulhardt HA, Moore KM, McMeekin DS, Schulz TK, Reed GA, Roby KF, Mackay CB, Smith HJ, Weir SJ, Wick JA, Markman M, diZerega GS, Baltezor MJ, Espinosa J, Decedue CJ. Williamson SK, et al. Among authors: wick ja. Cancer Chemother Pharmacol. 2015 May;75(5):1075-87. doi: 10.1007/s00280-015-2737-4. Epub 2015 Apr 23. Cancer Chemother Pharmacol. 2015. PMID: 25898813 Free PMC article. Clinical Trial.
331 results